FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(6), 1-11. https://eurekaoa.com/index.php/5/article/view/1148